The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity

Title
The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 127, Issue 9, Pages 2119-2128
Publisher
Wiley
Online
2010-02-09
DOI
10.1002/ijc.25233

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started